"Rising Demand for Ozempic and Weight-Loss Medications Fuels Gulf's Competitive Market"

The Gulf region, known for its high obesity rates, is experiencing a growing demand for weight-loss drugs like Ozempic. Originally developed as a treatment for Type 2 diabetes, Ozempic and its sister drug Wegovy have become popular off-label prescriptions for weight loss. The drugs work by slowing digestion, making patients feel full for longer periods. However, the surge in demand has led to shortages and calls for greater regulation. While these drugs have shown significant effectiveness in reducing body weight, there are concerns about potential side effects and the lack of medical supervision for those taking them without prescriptions.